Tissue plasminogen activator is required for the development of fetal alcohol syndrome in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 12, 2011, Pages 5069-5074

  Noel, Melissa ^a   Norris, Erin H ^a   Strickland, Sidney ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; CASPASE 3; DIAZEPAM; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYSIS; COGNITIVE DEFECT; DISEASE COURSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEAR; FETAL ALCOHOL SYNDROME; FOREBRAIN; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANIMALS; BEHAVIOR, ANIMAL; CASPASE 3; CENTRAL NERVOUS SYSTEM DEPRESSANTS; COGNITION DISORDERS; ETHANOL; FEMALE; FETAL ALCOHOL SYNDROME; HUMANS; MALE; MICE; MICE, KNOCKOUT; PREGNANCY; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; TISSUE PLASMINOGEN ACTIVATOR;

MUS;

EID: 79953177895     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1017608108     Document Type: Article

References (38)

1. Famy C, Streissguth AP, Unis AS (1998) Mental illness in adults with fetal alcohol syndrome or fetal alcohol effects. Am J Psychiatry 155:552-554. (Pubitemid 28207454)
2. Ikonomidou C, et al. (2000) Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287:1056-1060. (Pubitemid 30094364)
3. Ikonomidou C, et al. (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70-74. (Pubitemid 29044848)
4. Lovinger DM, White G, Weight FF (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243:1721-1724. (Pubitemid 19106970)
5. Mirshahi T, Woodward JJ (1995) Ethanol sensitivity of heteromeric NMDA receptors: Effects of subunit assembly, glycine and NMDAR1 Mg(2+)-insensitive mutants. Neuropharmacology 34:347-355.
6. Dikranian K, et al. (2001) Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis 8:359-379. (Pubitemid 32566129)
7. Olney JW, et al. (2002) Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol 12:488-498. (Pubitemid 35154937)
8. Baranes D, et al. (1998) Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21:813-825. (Pubitemid 28498789)
9. Norris EH, Strickland S (2007) Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system. Proc Natl Acad Sci USA 104:13473-13478. (Pubitemid 47293969)
10. Qian Z, Gilbert ME, Colicos MA, Kandel ER, Kuhl D (1993) Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and longterm potentiation. Nature 361:453-457. (Pubitemid 23050134)
11. Chen ZL, Strickland S (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91:917-925.
12. Tsirka SE, Gualandris A, Amaral DG, Strickland S (1995) Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377:340-344.
13. Pawlak R, Melchor JP, Matys T, Skrzypiec AE, Strickland S (2005) Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors. Proc Natl Acad Sci USA 102:443-448. (Pubitemid 40116786)
14. Young C, et al. (2003) Ethanol-induced neuronal apoptosis in vivo requires BAX in the developing mouse brain. Cell Death Differ 10:1148-1155. (Pubitemid 37258580)
15. Grenett HE, et al. (2001) Identification of a 251-bp fragment of the PAI-1 gene promoter that mediates the ethanol-induced suppression of PAI-1 expression. Alcohol Clin Exp Res 25:629-636. (Pubitemid 32448620)
16. Wozniak DF, et al. (2004) Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults. Neurobiol Dis 17:403-414. (Pubitemid 39574874)
17. Ghosh AP, et al. (2009) The proapoptotic BH3-only, Bcl-2 family member, Puma is critical for acute ethanol-induced neuronal apoptosis. J Neuropathol Exp Neurol 68:747-756.
18. Olney JW, Ishimaru MJ, Bittigau P, Ikonomidou C (2000) Ethanol-induced apoptotic neurodegeneration in the developing brain. Apoptosis 5:515-521. (Pubitemid 32182549)
19. Widmer F, Caroni P (1993) Phosphorylation-site mutagenesis of the growth-associated protein GAP-43 modulates its effects on cell spreading and morphology. J Cell Biol 120:503-512. (Pubitemid 23040088)
20. Tsirka SE, Rogove AD, Strickland S (1996) Neuronal cell death and tPA. Nature 384: 123-124.
21. Xu J, Ling EA (1994) Studies of the ultrastructure and permeability of the blood-brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers. J Anat 184:227-237. (Pubitemid 24114584)
22. Liebner S, et al. (2008) Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol 183:409-417.
23. Paul J, Strickland S, Melchor JP (2007) Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J Exp Med 204:1999-2008. (Pubitemid 47236333)
24. Coan EJ, Saywood W, Collingridge GL (1987) MK-801 blocks NMDA receptor-mediated synaptic transmission and long term potentiation in rat hippocampal slices. Neurosci Lett 80:111-114. (Pubitemid 17129781)
25. Study RE, Barker JL (1981) Diazepam and (-)-pentobarbital: Fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci USA 78:7180-7184.
26. Fischer G, et al. (1997) Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. J Pharmacol Exp Ther 283:1285-1292. (Pubitemid 28016504)
27. Park L, et al. (2008) Key role of tissue plasminogen activator in neurovascular coupling. Proc Natl Acad Sci USA 105:1073-1078. (Pubitemid 351282083)
28. Swayze VW, 2nd, et al. (1997) Magnetic resonance imaging of brain anomalies in fetal alcohol syndrome. Pediatrics 99:232-240.
29. Rivkin MJ, et al. (2008) Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana. Pediatrics 121:741-750.
30. Mattson SN, et al. (1996) A decrease in the size of the basal ganglia in children with fetal alcohol syndrome. Alcohol Clin Exp Res 20:1088-1093. (Pubitemid 26314836)
31. Bookstein FL, Streissguth AP, Sampson PD, Connor PD, Barr HM (2002) Corpus callosum shape and neuropsychological deficits in adult males with heavy fetal alcohol exposure. Neuroimage 15:233-251. (Pubitemid 34852223)
32. Benn SC, Woolf CJ (2004) Adult neuron survival strategies - slamming on the brakes. Nat Rev Neurosci 5:686-700. (Pubitemid 39150140)
33. Park L, et al. (2008) Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad Sci USA 105:1347-1352. (Pubitemid 351397056)
34. Chen C, Kim JJ, Thompson RF, Tonegawa S (1996) Hippocampal lesions impair contextual fear conditioning in two strains of mice. Behav Neurosci 110:1177-1180. (Pubitemid 26365816)
35. Gualandris A, Jones TE, Strickland S, Tsirka SE (1996) Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J Neurosci 16:2220-2225. (Pubitemid 26154333)
36. Deutsch DG, Mertz ET (1970) Plasminogen: Purification from human plasma by affinity chromatography. Science 170:1095-1096.
37. Salles FJ, Strickland S (2002) Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J Neurosci 22:2125-2134. (Pubitemid 35386512)
38. Schmued LC, Hopkins KJ (2000) Fluoro-Jade B: A high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874:123-130.